Stars align as ex-True North team nabs another $90M to build out biotech constellation

Star Therapeutics, which created two antibody-focused biotech startups with more in the works, has now reeled in a $90 million Series C.

The round, disclosed Tuesday morning, brings the Bay Area biotech’s total financing to more than $190 million since emerging from Westlake Village BioPartners in early 2022.

Star’s biotech…
Click here to view original post